142 related articles for article (PubMed ID: 3040737)
21. Is Ca2+ antagonists binding protein from cytosolic fraction the precursor of alpha 1-subunit of Ca2+ channel?
Krizanová O; Hudecová S; Orlický J; Zachar J
Gen Physiol Biophys; 1989 Apr; 8(2):99-111. PubMed ID: 2550315
[TBL] [Abstract][Full Text] [Related]
22. Phosphorylation of the 1,4-dihydropyridine receptor of the voltage-dependent Ca2+ channel by an intrinsic protein kinase in isolated triads from rabbit skeletal muscle.
Imagawa T; Leung AT; Campbell KP
J Biol Chem; 1987 Jun; 262(17):8333-9. PubMed ID: 2439499
[TBL] [Abstract][Full Text] [Related]
23. A rapid procedure for the purification of cardiac 1,4-dihydropyridine receptors from porcine heart.
Haase H; Striessnig J; Holtzhauer M; Vetter R; Glossmann H
Eur J Pharmacol; 1991 May; 207(1):51-9. PubMed ID: 1655494
[TBL] [Abstract][Full Text] [Related]
24. Dihydropyridine and phenylalkylamine receptors associated with cardiac and skeletal muscle calcium channels are structurally different.
Chang FC; Hosey MM
J Biol Chem; 1988 Dec; 263(35):18929-37. PubMed ID: 2848812
[TBL] [Abstract][Full Text] [Related]
25. (-)-[3H] desmethoxyverapamil labels multiple calcium channel modulator receptors in brain and skeletal muscle membranes: differentiation by temperature and dihydropyridines.
Reynolds IJ; Snowman AM; Snyder SH
J Pharmacol Exp Ther; 1986 Jun; 237(3):731-8. PubMed ID: 3012067
[TBL] [Abstract][Full Text] [Related]
26. Dihydropyridine-sensitive Ca2+ channels: molecular properties of interaction with Ca2+ channel blockers, purification, subunit structure, and differentiation.
Lazdunski M; Barhanin J; Borsotto M; Fosset M; Galizzi JP; Renaud JF; Romey G; Schmid A
J Cardiovasc Pharmacol; 1986; 8 Suppl 8():S13-9. PubMed ID: 2433514
[TBL] [Abstract][Full Text] [Related]
27. Calcium ions inhibit the allosteric interaction between the dihydropyridine and phenylalkylamine binding site on the voltage-gated calcium channel in heart sarcolemma but not in skeletal muscle transverse tubules.
Murphy BJ; Tuana BS
Can J Physiol Pharmacol; 1990 Nov; 68(11):1389-95. PubMed ID: 1962734
[TBL] [Abstract][Full Text] [Related]
28. Identification of the benzothiazepine-binding polypeptide of skeletal muscle calcium channels with (+)-cis-azidodiltiazem and anti-ligand antibodies.
Striessnig J; Scheffauer F; Mitterdorfer J; Schirmer M; Glossmann H
J Biol Chem; 1990 Jan; 265(1):363-70. PubMed ID: 2152924
[TBL] [Abstract][Full Text] [Related]
29. Characterization of the 1,4-dihydropyridine receptor using subunit-specific polyclonal antibodies. Evidence for a 32,000-Da subunit.
Sharp AH; Campbell KP
J Biol Chem; 1989 Feb; 264(5):2816-25. PubMed ID: 2536724
[TBL] [Abstract][Full Text] [Related]
30. Identification of 1,4-dihydropyridine binding regions within the alpha 1 subunit of skeletal muscle Ca2+ channels by photoaffinity labeling with diazipine.
Nakayama H; Taki M; Striessnig J; Glossmann H; Catterall WA; Kanaoka Y
Proc Natl Acad Sci U S A; 1991 Oct; 88(20):9203-7. PubMed ID: 1656465
[TBL] [Abstract][Full Text] [Related]
31. Control of expression of the 1,4-dihydropyridine receptor in BC3H1 cells.
Rampe D; Caffrey JM; Schneider MD; Brown AM
Biochem Biophys Res Commun; 1988 Apr; 152(2):769-75. PubMed ID: 2835042
[TBL] [Abstract][Full Text] [Related]
32. Rabbit skeletal muscle microsomes contain two distinct phenylalkylamine-binding sites.
Wernet W; Sieber M; Landgraf W; Hofmann F
Eur J Biochem; 1988 Feb; 172(1):233-8. PubMed ID: 2450023
[TBL] [Abstract][Full Text] [Related]
33. Kinetics of binding of dihydropyridine calcium channel ligands to skeletal muscle membranes: evidence for low-affinity sites and for the involvement of G proteins.
Dunn SM; Bladen C
Biochemistry; 1991 Jun; 30(23):5716-21. PubMed ID: 1645998
[TBL] [Abstract][Full Text] [Related]
34. Subunit composition of skeletal muscle transverse tubule calcium channels evaluated with the 1,4-dihydropyridine photoaffinity probe, [3H]azidopine.
Ferry DR; Kämpf K; Goll A; Glossmann H
EMBO J; 1985 Aug; 4(8):1933-40. PubMed ID: 2415355
[TBL] [Abstract][Full Text] [Related]
35. [3H]HOE166 defines a novel calcium antagonist drug receptor--distinct from the 1,4 dihydropyridine binding domain.
Grassegger A; Striessnig J; Weiler M; Knaus HG; Glossmann H
Naunyn Schmiedebergs Arch Pharmacol; 1989 Dec; 340(6 Pt 2):752-9. PubMed ID: 2561307
[TBL] [Abstract][Full Text] [Related]
36. Interaction between calcium channel ligands and calcium channels.
Glossmann H; Striessnig J; Ferry DR; Goll A; Moosburger K; Schirmer M
Circ Res; 1987 Oct; 61(4 Pt 2):I30-6. PubMed ID: 2443273
[TBL] [Abstract][Full Text] [Related]
37. Calcium binding to extracellular sites of skeletal muscle calcium channels regulates dihydropyridine binding.
Ebata H; Mills JS; Nemcek K; Johnson JD
J Biol Chem; 1990 Jan; 265(1):177-82. PubMed ID: 2152918
[TBL] [Abstract][Full Text] [Related]
38. [3H]PN200-110 binding in a fibroblast cell line transformed with the alpha 1 subunit of the skeletal muscle L-type Ca2+ channel.
Rampe D; Kim HS; Lacerda AE; Birnbaumer L; Brown AM
Biochem Biophys Res Commun; 1990 Jun; 169(3):825-31. PubMed ID: 2163635
[TBL] [Abstract][Full Text] [Related]
39. Identification of the site of interaction of the dihydropyridine channel blockers nitrendipine and azidopine with the calcium-channel alpha 1 subunit.
Regulla S; Schneider T; Nastainczyk W; Meyer HE; Hofmann F
EMBO J; 1991 Jan; 10(1):45-9. PubMed ID: 1846597
[TBL] [Abstract][Full Text] [Related]
40. Purification of the dihydropyridine receptor of the voltage-dependent Ca2+ channel from skeletal muscle transverse tubules using (+) [3H]PN 200-110.
Borsotto M; Barhanin J; Norman RI; Lazdunski M
Biochem Biophys Res Commun; 1984 Aug; 122(3):1357-66. PubMed ID: 6089781
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
